BIMI International Medical

BIMI International Medical, Inc. engages in the provision of healthcare products and services. It operates through the following segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. The Wholesale Pharmaceuticals segment includes supplying prescription and OTC medicines, TCM, healthcare supplies and sundry items to clinics, third party pharmacies, hospitals, and other drug vendors. The Wholesale Medical Devices segment distributes medical devices, including medical consumables to drug stores, private clinics, pharmaceutical dealers and hospitals. The Medical Services segment includes the hospitals acquired in 2021.The Retail Pharmacy segment sells prescription and OTC medicines, traditional Chinese medicines (“TCM”), healthcare supplies, and sundry items to retail customers through its directly-owned pharmacies and authorized retail stores. The company was founded on October 31, 2000 and is headquartered in Chongqing, China.

Earnings data Q4 2019

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BIMI International Medical, Inc. engages in the provision of healthcare products and services. It operates through the following segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. The Wholesale Pharmaceuticals segment includes supplying prescription and OTC medicines, TCM, healthcare supplies and sundry items to clinics, third party pharmacies, hospitals, and other drug vendors. The Wholesale Medical Devices segment distributes medical devices, including medical consumables to drug stores, private clinics, pharmaceutical dealers and hospitals. The Medical Services segment includes the hospitals acquired in 2021.The Retail Pharmacy segment sells prescription and OTC medicines, traditional Chinese medicines (“TCM”), healthcare supplies, and sundry items to retail customers through its directly-owned pharmacies and authorized retail stores. The company was founded on October 31, 2000 and is headquartered in New York, NY.

NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it closed a private placement of $5,400,000 of its senior convertible notes (the “Convertible Notes”) to two existing institutional investors (the “Investors”).  The closing took place on February 26, 2021.

Correction: BOQI International Medical Raised $4.5 Million In A Private Placement of Senior Convertible Notes

NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it closed a private placement of $5,400,00 of its senior convertible notes (the “Convertible Notes”) to two existing institutional investors (the “Investors”). The closing took place on February 26, 2021.

BOQI International Medical Raised $4.5 Million In A Private Placement of Senior Convertible Notes

NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announces that it has entered into an amendment to the Securities Purchase Agreement with two institutional investors (the “Investors”) that was previously announced on May 19, 2020. The Amendment increases the principal amount of senior convertible promissory notes to be purchased by the Investors.

BOQI International Medical Enters into An Amendment to the Securities Purchase Agreement to Increase the Principal Amount of Senior Convertible Promissory Notes to Be Purchased by Two Institutional Investors

New York, Feb. 10, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it had completed the acquisition of Chaohu Zhongshan Minimally Invasive Hospital (“Zhongshan Hospital”).

BOQI International Medical Announces Closing of the Acquisition of Chaohu Zhongshan Minimally Invasive Hospital

NEW YORK, Feb. 08, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it had completed the acquisition of Chongqing Guoyitang Hospital Co., Ltd. (“Guoyitang”).

BOQI International Medical Announces Closing of the Acquisition of Chongqing Guoyitang Hospital

NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced the closing of the previously announced sale of its BOQI Zhengji Pharmacy Chain (“Zhengji Pharmacy”). The transaction closed on February 2, 2021, at which time the Company received the agreed upon consideration of US$ 1,700,000.

BOQI International Medical Announces Receipt of $1.7 Million from Closing of the Sale of One of Its Pharmacy Chains

New York, Dec. 16, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered into a Stock Purchase Agreement (the “Agreement”) on December 15, 2020, to acquire Chaohu Zhongshan Minimally Invasive Hospital (“Zhongshan Hospital”), a private hospital in the southeast region of China with 65 hospital beds, 25 medical doctors, 22 medical technicians and 45 nurses. Zhongshan Hospital is a general hospital known for its complex minimally invasive surgeries. 

BOQI International Medical Signs Material Definitive Agreement to Acquire Chaohu Zhongshan Minimally Invasive Hospital

New York, Dec. 15, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has signed a Stock Purchase Agreement (the “Agreement”) on December 14, 2020, to acquire Chongqing Cogmer Biology Technology Co., Ltd. (“Cogmer”), a distributor of medical devices including in vitro diagnostic devices. Cogmer is focused on sales to hospitals and sub-distributors in the southwest region of China.

BOQI International Medical Signs Stock Purchase Agreement to Acquire Chongqing Cogmer Biology Technology Co., Ltd.

New York, Dec. 14, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has signed definitive agreements to sell BOQI Zhengji Pharmacy Chain Co., Ltd. (“Zhengji Pharmacy”), the owner and operator of 16 pharmacies in the city of Dalian of China.

BOQI International Medical Inc. to Sell One of Its Pharmacy Chain

New York, Dec. 09, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered into a Stock Purchase Agreement (the “Agreement”) on December 7, 2020, to acquire Chongqing Guoyitang Hospital (“Guoyitang”), the owner and operator of a private general hospital in Chongqing City, a southwest city of China, with 100 hospital beds, 53 medical doctors, 40 medical technicians, 50 nurses and 57 administrative employees.

BOQI International Medical Enters into Stock Purchase Agreement to Acquire Chongqing Guoyitang Hospital

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announces the signing of a Memorandum of Understanding (MOU) with Chaohu Zhongshan Minimally Invasive Hospital (“Chaohu Hospital”) on November 27, 2020.

BOQI International Medical Inc. Enters into MOU to Acquire Chaohu Zhongshan Minimally Invasive Hospital

NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced its financial results for the third quarter and nine months ended September 30, 2020.

BOQI International Medical Inc. Announces Third Quarter 2020 Financial Results

NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announces the signing of a Memorandum of Understanding (MoU) with Chongqing Cogmer Biology Technology Co., Ltd (“Cogmer Biology”) on October 28, 2020.

BOQI International Medical Inc. Enters into MOU with Chongqing Cogmer Biology Technology Co., Ltd

NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today provided an update on the development  of  an eProcurement platform,  supply-chain-management software and telemedicine software for the healthcare industry by its wholly-owned subsidiary, Dalian BOYI Technology Co., Ltd.

Update: BOQI International Medical Forms New Subsidiary, BOYI Technology, To Generate Revenue in Healthcare Technology Industry

NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announces the signing of a Memorandum of Understanding (MoU) with Chongqing Guoyitang Hospital Co., Ltd(“Chongqing Guoyitang Hospital”) on October 22, 2020.

BOQI International Medical Inc. Enters into MOU to Acquire Chongqing Guoyitang Hospital

NEW YORK, Oct. 19, 2020 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced its financial results for the second quarter and six months ended June 30, 2020.

BOQI International Medical Inc. Announces Second Quarter 2020 Financial Results, Revenue increased by 1026% Over the Same Period Last Year

New York, Aug.  24, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) reported that on August 21, 2020, it received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended June 30, 2020 (the “Form 10-Q”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. 

BOQI International Medical Announces Nasdaq Notification of Deficiency

New York, July  27, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) announced that at the Company’s Annual Meeting of Shareholders held on July 24, 2020, its shareholders overwhelmingly voted to approve, in accordance with Nasdaq Marketplace Rule 5635(d), the issuance of shares of the Company’s common stock upon (i) conversion of $4.45 million of senior secured convertible notes sold to two institutional investors (the “Institutional Investors”) on June 2, 2020; (ii) conversion of up to $2.10 million of additional senior secured convertible notes that may be sold to the Institutional Investors; (iii) exercise of up to 1,300,000 warrants issued to the Institutional Investors; and (iv) exercise of warrants to initially purchase 171,845 shares of the Company’s common stock, subject to increase under certain circumstances,  to the placement agent for the private placement of the above securities to the Institutional Investors.

BOQI International Medical Announces Shareholder Approval of Issuance of Securities

NEW YORK, June  29, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced its financial results for the fiscal quarter ended March 31, 2020.

BOQI International Medical Announces First Quarter 2020 Financial Results

New York, June  24, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced the closing of the previously announced sale of its legacy energy saving enhancement business.

BOQI International Medical Announces Closing of Energy Business Spin-Off

New York, June  04, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced the closing of its previously announced sale of $4.45 million of a new series of senior secured convertible notes (the “Convertible Notes”) with an original issue discount of 19.85% and ranking senior to all outstanding and future indebtedness of the Company in a private placement to two institutional investors. Additional Convertible Notes in an aggregate original principal amount not to exceed $2,100,000 may also be issued to the institutional investors at a later date under certain circumstances. The Convertible Notes do not bear interest except upon the occurrence of an event of default.

BOQI International Medical Announces Closing of Previously Announced Sale of Senior Secured Convertible Notes and Warrants

New York, May  19, 2020  (GLOBE NEWSWIRE) -- In a release issued under the same headline on May 19, 2020 by BOQI International Medical Inc. (NASDAQ: BIMI), in the third paragraph, the discount to the amortization conversion price should have been 22%, not 78%. The corrected release follows:

Correction: BOQI International Medical Enters into Securities Purchase Agreement

New York, May  19, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered into a securities purchase agreement (the “SPA”) with two institutional investors to sell a new series of senior secured convertible notes of the Company in a private placement, in the aggregate principal amount of up to $6,550,000. The offering is subject to customary closing conditions and is expected to close on or about May 22, 2020.

BOQI International Medical Enters into Securities Purchase Agreement

﻿New York, May  18, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has entered into a Memorandum of Understanding (“MOU”)  to acquire Chongqing Shanfeng Zhiyuan Biotechnology Co., Ltd. (“Chongqing Shanfeng Zhiyuan”) through its wholly-owned subsidiary Beijing Xin Rong Xin Industrial Development Co., Ltd.

BOQI International Medical Enters into MOU to acquire Chongqing Shanfeng Zhiyuan Biotechnology

NEW YORK, May  15, 2020  (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI)  (“BIMI” or the “Company”) announced its financial results for the fiscal year ended December 31, 2019.

News for BIMI International Medical Stock (BIMI)